AstraZeneca and Daiichi Sankyo launch clinical trial collaboration for Datroway

Statements (3)

1. ● Neutral

   Daiichi Sankyo and AstraZenca entered into a clinical trial collaboration agreement with Summit Therapeutics to evaluate Datroway Plus Ivonescimab

   nasdaq.comOct 2, 2026 06:59 UTCHigh importance
2. ● Neutral

   AstraZeneca and Daiichi Sankyo announced a clinical collaboration with Summit Therapeutics to evaluate Datroway in combination with ivonescimab across multiple tumour types

   news.cision.comOct 2, 2026 06:31 UTC
3. ● Neutral

   Daiichi Sankyo and AstraZeneca entered into a clinical trial collaboration agreement with Summit Therapeutics to evaluate Datroway in combination with ivonescimab

   businesswire.comOct 2, 2026 06:30 UTCHigh importance